Immage Biotherapeutics Corp.
IMMG
$0.00
$0.000.00%
OTC PK
| 02/28/2017 | 11/30/2016 | 08/31/2016 | 05/31/2016 | 02/29/2016 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -83.62% | -66.87% | 501.53% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 822.22% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -82.61% | -65.33% | 510.12% | 254.00% | -- |
|
|
|||||
| Total Current Assets | -82.61% | -65.33% | 510.12% | 254.00% | -- |
| Net Property, Plant & Equipment | -22.59% | -21.41% | -20.30% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | -3.33% | -4.84% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -75.44% | -60.53% | 203.12% | 306.80% | -- |
|
|
|||||
| Total Accounts Payable | -27.38% | 510.13% | -14.29% | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 6.63% | 9.92% | 10.23% | 8.20% | 138.91% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -1.58% | 76.12% | 8.56% | -3.46% | 94.41% |
|
|
|||||
| Total Current Liabilities | -1.58% | 76.12% | 8.56% | -3.46% | 94.41% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 6.63% | 9.92% | 10.23% | 8.20% | 138.91% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -1.58% | -76.34% | 8.56% | -3.46% | 94.41% |
|
|
|||||
| Common Stock & APIC | 316.26% | 1,672.46% | 0.62% | -- | -- |
| Retained Earnings | -962.00% | -1,539.29% | -250.46% | -247.98% | -306.85% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -92.57% | 1,352.83% | 550.35% | 1,357.89% | 938.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -92.57% | 1,352.83% | 550.35% | 1,357.89% | 938.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -92.57% | 1,352.83% | 550.35% | -- | -- |
|
|
|||||